GlassScriptPhysician profile
Lori S Berman
NPI 1942229653
$2,849.37
in general payments reported to CMS, 2019-2025
24 companies · $486 in 2025
The $486 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $249 · 2021: $458 · 2022: $303 · 2023: $599 · 2024: $341 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $829.68 | 2019-2025 | Penmenvy, Bexsero |
| Janssen Pharmaceuticals, INC | $360.91 | 2023-2024 | Xarelto |
| Kaleo, INC. | $216.27 | 2020-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $209.15 | 2019-2025 | Gardasil 9, Vaxneuvance, Proquad |
| Pfizer INC. | $185.95 | 2019-2023 | |
| Cranial Technologies, INC | $169.30 | 2020-2025 | Doc Band |
| Novo Nordisk INC | $144.27 | 2025 | Wegovy, Saxenda |
| Sanofi-Aventis U.S. LLC | $127.64 | 2024 | |
| Genentech USA, INC. | $99.33 | 2019-2021 | |
| Sobi, INC | $72.76 | 2019-2023 | |
| Vertical Pharmaceuticals, LLC | $59.12 | 2019-2024 | Relexxii |
| Alk-Abello, INC | $54.43 | 2023-2025 | Neffy, Grastek, Odactra |
| Hologic Sales and Service, LLC | $40.24 | 2022-2024 | Aptima |
| Neos Therapeutics, LP | $39.08 | 2025 | Cotempla Xr-Odt |
| Aytu Biopharma, INC. | $38.39 | 2024 | Karbinal |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $34.75 | 2024 | |
| Corium, LLC | $33.20 | 2023-2025 | Azstarys |
| Acadia Pharmaceuticals INC | $23.01 | 2025 | Daybue |
| Organon LLC | $20.54 | 2022 | |
| Meridian Bioscience INC. | $19.86 | 2020 | |
| Almirall LLC | $19.75 | 2022 | |
| Shire North American Group INC | $19.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.99 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.44 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.